Crossref journal-article
Elsevier BV
Urology (78)
Bibliography

Magklara, A., Scorilas, A., Stephan, C., Kristiansen, G. O., Hauptmann, S., Jung, K., & Diamandis, E. P. (2000). Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue. Urology, 56(3), 527–532.

Authors 7
  1. Angeliki Magklara (first)
  2. Andreas Scorilas (additional)
  3. Carsten Stephan (additional)
  4. Glen O Kristiansen (additional)
  5. Steffen Hauptmann (additional)
  6. Klaus Jung (additional)
  7. Eleftherios P Diamandis (additional)
References 29 Referenced 79
  1. 10.1016/S1043-2760(98)00082-4 / Trends Endocrinol Metab / Prostate-specific antigen—its usefulness in clinical medicine by Diamandis (1998)
  2. 10.1001/jama.279.19.1542 / JAMA / Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease by Catalona (1998)
  3. 10.1002/ijc.2910550413 / Int J Cancer / Evaluation of PAP and PSA gene expression in prostatic hyperplasia and prostatic carcinoma using Northern blot analyses, in situ hybridization and immunohistochemical stainings with monoclonal and bispecific antibodies by Hakalahti (1993)
  4. 10.1007/BF00295844 / Urol Res / Variation of prostate specific antigen expression in different tumour growth patterns present in prostatectomy specimens by Gallee (1990)
  5. 10.1002/ijc.2910490503 / Int J Cancer / Tissue concentrations of prostate specific antigen in prostatic carcinoma and benign prostatic hyperplasia by Pretlow (1991)
  6. 10.1002/ijc.2910450414 / Int J Cancer / Expression of the gene coding for human prostate specific antigen and related hGK-1 in benign and malignant tumors of the human prostate by Henttu (1990)
  7. 10.1016/S0022-5347(17)39797-5 / J Urol / In situ hybridization of prostate specific antigen mRNA in human prostate by Qiu (1990)
  8. {'key': '10.1016/S0090-4295(00)00621-X_BIB8', 'first-page': '160', 'article-title': 'Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas', 'volume': '6', 'author': 'Stege', 'year': '2000', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas by Stege (2000)
  9. 10.1080/10408369891234219 / Crit Rev Clin Lab Sci / Human kallikrein 2 (hK2) and prostate-specific antigen (PSA) by Rittenhouse (1998)
  10. 10.1016/S1043-2760(99)00225-8 / Trends Endocrinol Metab / The human kallikrein gene family—in carcinogenesis by Diamandis (2000)
  11. 10.1006/bbrc.1997.7333 / Biochem Biophys Res Commun / Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2 by Lovgren (1997)
  12. {'key': '10.1016/S0090-4295(00)00621-X_BIB12', 'first-page': '3111', 'article-title': 'Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2', 'volume': '57', 'author': 'Kumar', 'year': '1997', 'journal-title': 'Cancer Res'} / Cancer Res / Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2 by Kumar (1997)
  13. 10.1074/jbc.272.34.21582 / J Biol Chem / Characterization of the precursor of prostate-specific antigen by Takayama (1997)
  14. 10.1016/S0090-4295(98)00245-3 / Urology / In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic “gray zone” of total PSA 4 to 10 ng/mL by Kwiatkowski (1998)
  15. 10.1093/clinchem/45.11.1960 / Clin Chem / The combination of human glandular kallikrein and free prostate-specific antigen (PSA) enhances discrimination between prostate cancer and benign prostatic hyperplasia in patients with moderately increased total PSA by Magklara (1999)
  16. 10.1016/S0090-4295(97)00108-8 / Urology / Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma by Darson (1997)
  17. 10.1016/S0090-4295(98)00637-2 / Urology / Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases by Darson (1999)
  18. 10.1002/(SICI)1097-0215(19971219)74:6<630::AID-IJC13>3.0.CO;2-9 / Int J Cancer / Factors influencing the ratio of free to total prostate-specific antigen in serum by Meyer (1997)
  19. 10.1093/clinchem/46.1.47 / Clin Chem / Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue by Jung (2000)
  20. 10.1093/clinchem/42.5.675 / Clin Chem / Ultrasensitive detection of prostate specific antigen by a time-resolved immunofluorometric assay and the Immulite Immunochemiluminescent third generation assay by Ferguson (1996)
  21. 10.1093/clinchem/45.6.790 / Clin Chem / Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross reactivity from prostate specific antigen by Black (1999)
  22. 10.1093/jnci/91.19.1635 / J Natl Cancer Inst / Antiangiogenic activity of prostate-specific antigen by Fortier (1999)
  23. 10.1038/sj.bjc.6692167 / Br J Cancer / Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen by Heidtmann (1999)
  24. 10.1093/clinchem/45.6.800 / Clin Chem / Highly sensitive automated chemiluminometric assay for measuring free human glandular kallikrein-2 by Klee (1999)
  25. 10.1093/clinchem/42.7.1034 / Clin Chem / Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum by Piironen (1996)
  26. 10.1054/bjoc.1999.0927 / Br J Cancer / Expression of a prostate associated protein, human glandular kallikrein (hK2) in breast tumors and in normal breast secretions by Black (2000)
  27. {'key': '10.1016/S0090-4295(00)00621-X_BIB27', 'first-page': '2651', 'article-title': 'Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D', 'volume': '57', 'author': 'Hsieh', 'year': '1997', 'journal-title': 'Cancer Res'} / Cancer Res / Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D by Hsieh (1997)
  28. 10.1023/A:1006304518750 / Breast Cancer Res Treat / Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate specific antigen (PSA) in breast cancer cell lines by Magklara (2000)
  29. 10.1200/JCO.2000.18.5.1036 / J Clin Oncol / Serum human glandular kallikrein-2 protease levels predict the presence of prostate cancer among men with elevated prostate specific antigen by Nam (2000)
Dates
Type When
Created 23 years, 1 month ago (July 25, 2002, 12:24 p.m.)
Deposited 4 years, 3 months ago (May 8, 2021, 9:44 a.m.)
Indexed 1 day, 18 hours ago (Aug. 27, 2025, 11:45 a.m.)
Issued 24 years, 11 months ago (Sept. 1, 2000)
Published 24 years, 11 months ago (Sept. 1, 2000)
Published Print 24 years, 11 months ago (Sept. 1, 2000)
Funders 0

None

@article{Magklara_2000, title={Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue}, volume={56}, ISSN={0090-4295}, url={http://dx.doi.org/10.1016/s0090-4295(00)00621-x}, DOI={10.1016/s0090-4295(00)00621-x}, number={3}, journal={Urology}, publisher={Elsevier BV}, author={Magklara, Angeliki and Scorilas, Andreas and Stephan, Carsten and Kristiansen, Glen O and Hauptmann, Steffen and Jung, Klaus and Diamandis, Eleftherios P}, year={2000}, month=sep, pages={527–532} }